StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca share capital ($0.25 Ordinary Shares) ($M) ($M)

Consolidated Statement of Financial Position (Postgres DB)

QuarterlyAnnual
Latest, Q2 2026
388
Period ended Jun 30, 2026
Change on a year earlier
0.0%
388 in Q2 2025
History
22 quarters
Since Q4 2015
Sources
18
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare capital ($0.25 Ordinary Shares) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263880.0%Form 6-K (filed 2026-07-27) ↗
Q4 2025Dec 31, 20253880.0%Form 20-F (filed 2026-02-24) ↗
Q2 2025Jun 30, 20253880.0%Form 6-K (filed 2025-07-29) ↗
Q4 2024Dec 31, 20243880.0%Form 20-F (filed 2025-02-18) ↗
Q2 2024Jun 30, 2024388+0.3%Form 6-K (filed 2024-07-25) ↗
Q4 2023Dec 31, 2023388+0.3%Form 20-F (filed 2024-02-20) ↗
Q2 2023Jun 30, 20233870.0%Form 6-K (filed 2023-07-28) ↗
Q4 2022Dec 31, 20223870.0%Form 20-F (filed 2023-02-21) ↗
Q2 2022Jun 30, 2022387+18.0%Form 6-K (filed 2022-07-29) ↗
Q4 2021Dec 31, 2021387+18.0%Form 20-F (filed 2022-02-22) ↗
Q2 2021Jun 30, 20213280.0%Form 6-K (filed 2021-07-30) ↗
Q4 2020Dec 31, 20203280.0%Form 20-F (filed 2021-02-16) ↗
Q2 2020Jun 30, 20203280.0%Form 6-K/A (filed 2020-07-31) ↗
Q4 2019Dec 31, 2019328+3.5%Form 20-F (filed 2020-03-03) ↗
Q2 2019Jun 30, 2019328+3.5%Form 6-K (filed 2019-07-25) ↗
Q1 2019Mar 31, 201911–Form 20-F (filed 2020-03-03) ↗

Cite this data

StockData. (2026). AstraZeneca Share capital ($0.25 Ordinary Shares) ($M) ($M), quarterly Q4 2015–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_common_stock

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.